These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22475747)

  • 21. Serial analysis of gene expression and cancer.
    Hermeking H
    Curr Opin Oncol; 2003 Jan; 15(1):44-9. PubMed ID: 12490760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
    Kempowsky-Hamon T; Valle C; Lacroix-Triki M; Hedjazi L; Trouilh L; Lamarre S; Labourdette D; Roger L; Mhamdi L; Dalenc F; Filleron T; Favre G; François JM; Le Lann MV; Anton-Leberre V
    BMC Med Genomics; 2015 Feb; 8():3. PubMed ID: 25888889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of supervised gene signatures of early hypoxia on patient survival.
    Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
    Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
    J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 27. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
    Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
    BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments.
    Xu JZ; Wong CW
    Cancer Lett; 2010 Oct; 296(1):9-16. PubMed ID: 20579805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
    Liu Y; Xiong S; Liu S; Chen J; Yang H; Liu G; Li G
    J Comput Biol; 2020 Jun; 27(6):987-998. PubMed ID: 31545079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    Kwon EJ; Ha M; Jang JY; Kim YH
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling in cancer from a bioinformatics prospective.
    Gusev Y; Brackett DJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
    Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
    Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray.
    Liu F; Xiong Y; Zhao Y; Tao L; Zhang Z; Zhang H; Liu Y; Feng G; Li B; He L; Ma J; Qin S; Yang Y
    Diagn Pathol; 2013 Sep; 8():158. PubMed ID: 24053158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential network analysis for the identification of condition-specific pathway activity and regulation.
    Gambardella G; Moretti MN; de Cegli R; Cardone L; Peron A; di Bernardo D
    Bioinformatics; 2013 Jul; 29(14):1776-85. PubMed ID: 23749957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    Kim N; Chung W; Eum HH; Lee HO; Park WY
    PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.
    Ertel A; Verghese A; Byers SW; Ochs M; Tozeren A
    Mol Cancer; 2006 Nov; 5(1):55. PubMed ID: 17081305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MERAV: a tool for comparing gene expression across human tissues and cell types.
    Shaul YD; Yuan B; Thiru P; Nutter-Upham A; McCallum S; Lanzkron C; Bell GW; Sabatini DM
    Nucleic Acids Res; 2016 Jan; 44(D1):D560-6. PubMed ID: 26626150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GeneAnalytics Pathways and Profiling of Shared Autism and Cancer Genes.
    Gabrielli AP; Manzardo AM; Butler MG
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do predictive signatures really predict response to cancer chemotherapy?
    Borst P; Wessels L
    Cell Cycle; 2010 Dec; 9(24):4836-40. PubMed ID: 21150277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.